{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T23:31:50Z","timestamp":1790638310682,"version":"4.1.0"},"reference-count":212,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2020,5,13]],"date-time":"2020-05-13T00:00:00Z","timestamp":1589328000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"DOI":"10.13039\/501100001321","name":"National Research Foundation","doi-asserted-by":"publisher","award":["117435 to A.T.J."],"award-info":[{"award-number":["117435 to A.T.J."]}],"id":[{"id":"10.13039\/501100001321","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001321","name":"National Research Foundation","doi-asserted-by":"publisher","award":["115566 to C.H.P."],"award-info":[{"award-number":["115566 to C.H.P."]}],"id":[{"id":"10.13039\/501100001321","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,1,4]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Although Candida albicans remains the main cause of candidiasis, in recent years a significant number of infections has been attributed to non-albicans Candida (NAC) species, including Candida krusei. This epidemiological change can be partly explained by the increased resistance of NAC species to antifungal drugs. C. krusei is a diploid, dimorphic ascomycetous yeast that inhabits the mucosal membrane of healthy individuals. However, this yeast can cause life-threatening infections in immunocompromised patients, with hematologic malignancy patients and those using prolonged azole prophylaxis being at higher risk. Fungal infections are usually treated with five major classes of antifungal agents which include azoles, echinocandins, polyenes, allylamines, and nucleoside analogues. Fluconazole, an azole, is the most commonly used antifungal drug due to its low host toxicity, high water solubility, and high bioavailability. However, C. krusei possesses intrinsic resistance to this drug while also rapidly developing acquired resistance to other antifungal drugs. The mechanisms of antifungal resistance of this yeast involve the alteration and overexpression of drug target, reduction in intracellular drug concentration and development of a bypass pathway. Antifungal resistance menace coupled with the paucity of the antifungal arsenal as well as challenges involved in antifungal drug development, partly due to the eukaryotic nature of both fungi and humans, have left researchers to exploit alternative therapies. Here we briefly review our current knowledge of the biology, pathophysiology and epidemiology of a potential multidrug-resistant fungal pathogen, C. krusei, while also discussing the mechanisms of drug resistance of Candida species and alternative therapeutic approaches.<\/jats:p>","DOI":"10.1093\/mmy\/myaa031","type":"journal-article","created":{"date-parts":[[2020,4,14]],"date-time":"2020-04-14T07:10:12Z","timestamp":1586848212000},"page":"14-30","source":"Crossref","is-referenced-by-count":153,"title":["Update on\n                    <i>Candida krusei<\/i>\n                    , a potential multidrug-resistant pathogen"],"prefix":"10.1093","volume":"59","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9953-9169","authenticated-orcid":false,"given":"A T","family":"Jamiu","sequence":"first","affiliation":[{"name":"Pathogenic Yeast Research Group, Department of Microbial, Biochemical and Food Biotechnology, University of the Free State, Bloemfontein, South Africa, 9301"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Albertyn","sequence":"additional","affiliation":[{"name":"Pathogenic Yeast Research Group, Department of Microbial, Biochemical and Food Biotechnology, University of the Free State, Bloemfontein, South Africa, 9301"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O M","family":"Sebolai","sequence":"additional","affiliation":[{"name":"Pathogenic Yeast Research Group, Department of Microbial, Biochemical and Food Biotechnology, University of the Free State, Bloemfontein, South Africa, 9301"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C H","family":"Pohl","sequence":"additional","affiliation":[{"name":"Pathogenic Yeast Research Group, Department of Microbial, Biochemical and Food Biotechnology, University of the Free State, Bloemfontein, South Africa, 9301"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2020,5,13]]},"reference":[{"key":"2021010319002736900_bib1","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1126\/science.aaa6097","article-title":"How to bolster the antifungal pipeline","volume":"347","author":"Denning","year":"2015","journal-title":"Science"},{"key":"2021010319002736900_bib2","doi-asserted-by":"crossref","first-page":"165rv13","DOI":"10.1126\/scitranslmed.3004404","article-title":"Hidden killers: human fungal infections","volume":"4","author":"Brown","year":"2012","journal-title":"Sci Transl Med"},{"key":"2021010319002736900_bib3","first-page":"w14281","article-title":"Common invasive fungal diseases: an overview of invasive candidiasis, aspergillosis, cryptococcosis, and Pneumocystis pneumonia","volume":"146","author":"Schmiedel","year":"2016","journal-title":"Swiss Med Wkly"},{"key":"2021010319002736900_bib4","doi-asserted-by":"crossref","first-page":"S352","DOI":"10.1093\/cid\/ciu639","article-title":"Update on epidemiology of and preventive strategies for invasive fungal infections in cancer patients","volume":"59","author":"Perfect","year":"2014","journal-title":"Clin Infect Dis"},{"key":"2021010319002736900_bib5","doi-asserted-by":"crossref","first-page":"ii13","DOI":"10.1093\/jac\/dkw392","article-title":"The current treatment landscape: candidiasis","volume":"71","author":"Bassetti","year":"2016","journal-title":"J Antimicrob Chemother"},{"key":"2021010319002736900_bib6","doi-asserted-by":"crossref","first-page":"e129","DOI":"10.1371\/journal.ppat.0020129","article-title":"Fungal invasion of normally non-phagocytic host cells","volume":"2","author":"Filler","year":"2006","journal-title":"PLoS Pathog"},{"key":"2021010319002736900_bib7","volume-title":"Oral Candidosis","author":"Samaranayake","year":"1990"},{"key":"2021010319002736900_bib8","first-page":"226","article-title":"Fungal infections: a growing threat","volume":"111","author":"Dixon","year":"1996","journal-title":"Public Health Rep"},{"key":"2021010319002736900_bib9","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1128\/CMR.00029-06","article-title":"Epidemiology of invasive candidiasis: A persistent public health problem","volume":"20","author":"Pfaller","year":"2007","journal-title":"Clin Microbiol Rev"},{"key":"2021010319002736900_bib10","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1097\/CCM.0b013e31819efac0","article-title":"Epidemiology, management, and risk factors for death of invasive Candida infections in critical care: a multicenter, prospective, observational study in France (2005\u20132006)","volume":"37","author":"Leroy","year":"2009","journal-title":"Crit Care Med"},{"key":"2021010319002736900_bib11","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1056\/NEJMra1315399","article-title":"Invasive candidiasis","volume":"373","author":"Kullberg","year":"2015","journal-title":"N Engl J Med"},{"key":"2021010319002736900_bib12","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1128\/AAC.00966-12","article-title":"Synergistic Effects of amiodarone and fluconazole on Candida tropicalis resistant to fluconazole","volume":"57","author":"da Silva","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"2021010319002736900_bib13","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.mycmed.2017.12.008","article-title":"Emergence of non-Candida albicans species: epidemiology, phylogeny and fluconazole susceptibility profile","volume":"28","author":"Sadeghi","year":"2018","journal-title":"J Mycol Med"},{"key":"2021010319002736900_bib14","volume-title":"Candida and Candidosis","author":"Odds","year":"1988","edition":"2nd edn"},{"key":"2021010319002736900_bib15","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1038\/nature08064","article-title":"Evolution of pathogenicity and sexual reproduction in eight Candida genomes","volume":"459","author":"Butler","year":"2009","journal-title":"Nature"},{"key":"2021010319002736900_bib16","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1139\/w2012-077","article-title":"Candida krusei: biotechnological potentials and concerns about its safety","volume":"58","author":"Yadav","year":"2012","journal-title":"Can J Microbiol"},{"key":"2021010319002736900_bib17","doi-asserted-by":"crossref","first-page":"36","DOI":"10.3389\/fmicb.2017.00036","article-title":"Antifungal therapy: new advances in the understanding and treatment of mycosis","volume":"8","author":"Scorzoni","year":"2017","journal-title":"Front Microbiol"},{"key":"2021010319002736900_bib18","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1086\/524071","article-title":"Resistance to antifungal agents: mechanisms and clinical impact","volume":"46","author":"Kanafani","year":"2008","journal-title":"Clin Infect Dis"},{"key":"2021010319002736900_bib19","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1111\/myc.12330","article-title":"Antifungal drug resistance among Candida species: mechanisms and clinical impact","volume":"58","author":"Sanguinetti","year":"2015","journal-title":"Mycoses"},{"key":"2021010319002736900_bib20","first-page":"163","article-title":"Profile of isavuconazole and its potential in the treatment of severe invasive fungal infections","volume":"22","author":"Falci","year":"2013","journal-title":"Infect Drug Resist"},{"key":"2021010319002736900_bib21","doi-asserted-by":"crossref","first-page":"5678","DOI":"10.1016\/j.bmc.2012.04.045","article-title":"The biology and chemistry of antifungal agents: a review","volume":"20","author":"Kathiravan","year":"2012","journal-title":"Bioorg Med Chem"},{"key":"2021010319002736900_bib22","doi-asserted-by":"crossref","first-page":"877","DOI":"10.2165\/00003495-199039060-00006","article-title":"Fluconazole","volume":"39","author":"Grant","year":"1990","journal-title":"Drugs"},{"key":"2021010319002736900_bib23","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/S0924-8579(00)00258-2","article-title":"Current and future antifungal therapy: new targets for antifungal therapy","volume":"16","author":"Andriole","year":"2000","journal-title":"Int J Antimicrob Agents"},{"key":"2021010319002736900_bib24","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/7355_2016_4","article-title":"Past, present, and future of antifungal drug development","volume-title":"Communicable Diseases of the Developing World. Topics in Medicinal Chemistry","author":"Shukla","year":"2016"},{"key":"2021010319002736900_bib25","doi-asserted-by":"crossref","first-page":"2173","DOI":"10.3389\/fmicb.2016.02173","article-title":"Azole antifungal resistance in Candida albicans and emerging non-albicans Candida species","volume":"7","author":"Whaley","year":"2017","journal-title":"Front Microbiol"},{"key":"2021010319002736900_bib26","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1093\/cid\/civ1194","article-title":"Executive summary: clinical practice guideline for the management of candidiasis: 2016 update by the infectious diseases society of America","volume":"62","author":"Pappas","year":"2016","journal-title":"Clin Infect Dis"},{"key":"2021010319002736900_bib27","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1146\/annurev-micro-030117-020345","article-title":"Molecular evolution of antifungal drug resistance","volume":"71","author":"Robbins","year":"2017","journal-title":"Annu Rev Microbiol"},{"key":"2021010319002736900_bib28","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0140-6736(00)51698-5","article-title":"Observations on the fungi found in tropical bronchomycosis","volume":"179","author":"Castellani","year":"1912","journal-title":"The Lancet"},{"key":"2021010319002736900_bib29","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1099\/00222615-41-5-295","article-title":"Candida krusei: biology, epidemiology, pathogenicity and clinical manifestations of an emerging pathogen","volume":"41","author":"Samaranayake","year":"1994","journal-title":"J Medical Microbiol"},{"key":"2021010319002736900_bib30","volume-title":"The Systematics of Yeasts","author":"Kudryavtsev","year":"1960"},{"key":"2021010319002736900_bib31","first-page":"566","article-title":"The genus Pichia sensu lato","volume":"81","author":"Boidin","year":"1965","journal-title":"Bull Soc Mycol France"},{"key":"2021010319002736900_bib32","first-page":"1","article-title":"The genera of yeasts and yeast-like fungi","volume":"14","author":"Von Arx","year":"1977","journal-title":"Stud Mycol"},{"key":"2021010319002736900_bib33","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1023\/A:1001761008817","article-title":"Identification and phylogeny of ascomycetous yeasts from analysis of nuclear large subunit (26S) ribosomal DNA partial sequences","volume":"73","author":"Kurtzman","year":"1998","journal-title":"Antonie Leeuwenhoek"},{"key":"2021010319002736900_bib34","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1111\/j.1567-1364.2008.00419.x","article-title":"Phylogenetic relationships among species of Pichia, Issatchenkia and Williopsis determined from multigene sequence analysis, and the proposal of Barnettozyma gen. nov., Lindnera gen. nov. and Wickerhamomyces gen. nov","volume":"8","author":"Kurtzman","year":"2008","journal-title":"FEMS Yeast Res"},{"key":"2021010319002736900_bib35","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1099\/00207713-30-2-503","article-title":"Emendation of the genus Issatchenkia Kudriavzev and comparison of species by deoxyribonucleic acid reassociation, mating reaction, and ascospore ultrastructure","volume":"30","author":"Kurtzman","year":"1980","journal-title":"Int J Syst Bacteriol"},{"key":"2021010319002736900_bib36","doi-asserted-by":"crossref","first-page":"e1007138","DOI":"10.1371\/journal.ppat.1007138","article-title":"Population genomics shows no distinction between pathogenic Candida krusei and environmental Pichia kudriavzevii: one species, four names","volume":"14","author":"Douglass","year":"2018","journal-title":"PLoS Pathog"},{"key":"2021010319002736900_bib37","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1007\/BF00394135","article-title":"Heterothallism in Pichia kudriavzevii and Pichia terricola","volume":"42","author":"Kurtzman","year":"1976","journal-title":"Antonie Leeuwenhoek"},{"key":"2021010319002736900_bib38","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1099\/00222615-47-12-1047","article-title":"The relative pathogenicity of Candida krusei and C. albicans in the rat oral mucosa","volume":"47","author":"Samaranayake","year":"1998","journal-title":"J Med Microbiol"},{"key":"2021010319002736900_bib39","first-page":"34","article-title":"Morphology and identification of yeasts isolated from Toddy palm in Thailand","volume":"23","author":"Tuntiwongwanich","year":"2009","journal-title":"J Microsc Soc Thail"},{"key":"2021010319002736900_bib40","doi-asserted-by":"crossref","first-page":"4787","DOI":"10.1128\/JCM.41.10.4787-4789.2003","article-title":"Differentiation of Candida dubliniensis from Candida albicans on Pal's agar","volume":"41","author":"Al Mosaid","year":"2003","journal-title":"J Clin Microbiol"},{"key":"2021010319002736900_bib41","doi-asserted-by":"crossref","first-page":"5768","DOI":"10.1128\/JCM.43.11.5768-5770.2005","article-title":"Supplementation of CHROMagar Candida medium with Pal's medium for rapid identification of Candida dubliniensis","volume":"43","author":"Sahand","year":"2005","journal-title":"J Clin Microbiol"},{"key":"2021010319002736900_bib42","doi-asserted-by":"crossref","first-page":"2629","DOI":"10.1128\/JCM.41.6.2629-2632.2003","article-title":"Direct isolation of Candida spp. from blood cultures on the chromogenic medium CHROMagar Candida","volume":"41","author":"Horvath","year":"2003","journal-title":"J Clin Microbiol"},{"key":"2021010319002736900_bib43","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/S0255-0857(21)02775-4","article-title":"Onycholysis caused by Candida krusei","volume":"22","author":"Rao","year":"2004","journal-title":"Indian J Med Microbiol"},{"key":"2021010319002736900_bib44","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.ijfoodmicro.2011.12.030","article-title":"Food fermentations: Microorganisms with technological beneficial use","volume":"154","author":"Bourdichon","year":"2012","journal-title":"Int J Food Microbiol"},{"key":"2021010319002736900_bib45","first-page":"15","article-title":"The role and use of non-Saccharomyces yeasts in wine production","volume":"27","author":"Jolly","year":"2006","journal-title":"S Afr J Eno Vitic"},{"key":"2021010319002736900_bib46","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1046\/j.1365-2672.1999.00786.x","article-title":"Characterization of Candida krusei strains from spontaneously fermented maize dough by profiles of assimilation, chromosome profile, polymerase chain reaction and restriction endonuclease analysis","volume":"87","author":"Hayford","year":"1999","journal-title":"J Appl Microbiol"},{"key":"2021010319002736900_bib47","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1111\/j.1567-1364.2008.00384.x","article-title":"Candida krusei produces ethanol without production of succinic acid; a potential advantage for ethanol recovery by pervaporation membrane separation","volume":"8","author":"Nakayama","year":"2008","journal-title":"FEMS Yeast Res"},{"key":"2021010319002736900_bib48","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1099\/00222615-14-2-219","article-title":"Characterisation of pathogenic species of Candida by gas chromatography: preliminary findings","volume":"14","author":"Lategan","year":"1981","journal-title":"J Med Microbiol"},{"key":"2021010319002736900_bib49","first-page":"419","article-title":"Purification and properties of a phytase from Candida krusei WZ-001","volume":"94","author":"Quan","year":"2002","journal-title":"J Biosci Bioeng"},{"key":"2021010319002736900_bib50","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.ijantimicag.2008.10.033","article-title":"Effect of berberine on Staphylococcus epidermidis biofilm formation","volume":"34","author":"Wang","year":"2009","journal-title":"Int J Antimicrob Agents"},{"key":"2021010319002736900_bib51","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1097\/00003226-199605000-00012","article-title":"Biofilm formation in infectious crystalline keratopathy due to Candida albicans","volume":"15","author":"Elder","year":"1996","journal-title":"Cornea."},{"key":"2021010319002736900_bib52","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/S0966-842X(00)01918-1","article-title":"Cystic fibrosis pathogenesis and the role of biofilms in persistent infection","volume":"9","author":"Costerton","year":"2001","journal-title":"Trends Microbiol"},{"key":"2021010319002736900_bib53","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1093\/jac\/46.3.397","article-title":"Matrix polymers of Candida biofilms and their possible role in biofilm resistance to antifungal agents","volume":"46","author":"Baillie","year":"2000","journal-title":"J Antimicrob Chemother"},{"key":"2021010319002736900_bib54","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1034\/j.1601-0825.8.s2.6.x","article-title":"Fungal infections associated with HIV infection","volume":"8","author":"Samaranayake","year":"2002","journal-title":"Oral Dis"},{"key":"2021010319002736900_bib55","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/S0966-842X(02)00002-1","article-title":"Candida biofilms and their role in infection","volume":"11","author":"Douglas","year":"2003","journal-title":"Trends Microbiol"},{"key":"2021010319002736900_bib56","doi-asserted-by":"crossref","first-page":"449","DOI":"10.3349\/ymj.2014.55.2.449","article-title":"Influence of bacterial presence on biofilm formation of Candida albicans","volume":"55","author":"Park","year":"2014","journal-title":"Yonsei Med J"},{"key":"2021010319002736900_bib57","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1186\/1471-2180-10-125","article-title":"Pseudomonas aeruginosa inhibits in-vitro Candida biofilm development","volume":"10","author":"Bandara","year":"2010","journal-title":"BMC Microbiol"},{"key":"2021010319002736900_bib58","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1016\/j.archoralbio.2007.06.007","article-title":"Characteristics of dual species Candida biofilms on denture acrylic surfaces","volume":"52","author":"Thein","year":"2007","journal-title":"Arch Oral Biol"},{"key":"2021010319002736900_bib59","doi-asserted-by":"crossref","first-page":"e23","DOI":"10.1590\/1807-3107BOR-2016.vol30.0023","article-title":"Mixed biofilms formed by C. albicans and non-albicans species: a study of microbial interactions","volume":"30","author":"Santos","year":"2016","journal-title":"Braz Oral Res"},{"key":"2021010319002736900_bib60","doi-asserted-by":"crossref","first-page":"e0131700","DOI":"10.1371\/journal.pone.0131700","article-title":"Competitive interactions between C. albicans, C. glabrata and C. krusei during biofilm formation and development of experimental candidiasis","volume":"10","author":"Rossoni","year":"2015","journal-title":"PLoS One"},{"key":"2021010319002736900_bib61","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.archoralbio.2016.01.005","article-title":"Influence of Candida krusei and Candida glabrata on Candida albicans gene expression in in vitro biofilms","volume":"64","author":"Barros","year":"2016","journal-title":"Arch Oral Biol"},{"key":"2021010319002736900_bib62","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1007\/s12223-017-0500-4","article-title":"Candida krusei and Candida glabrata reduce the filamentation of Candida albicans by downregulating expression of HWP1 gene","volume":"62","author":"Barros","year":"2017","journal-title":"Folia Microbiol"},{"key":"2021010319002736900_bib63","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1590\/0103-6440201701393","article-title":"Study of microbial interaction formed by Candida krusei and Candida glabrata: in vitro and in vivo studies","volume":"28","author":"Rossoni","year":"2017","journal-title":"Braz Dent J"},{"key":"2021010319002736900_bib64","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1016\/j.funbio.2011.09.001","article-title":"Candida krusei and Kloeckera apis inhibit the causal agent of pineapple fusariosis","volume":"115","author":"Korres","year":"2011","journal-title":"Fusarium guttiforme. Fungal Biol."},{"key":"2021010319002736900_bib65","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/s12866-017-0972-z","article-title":"Candida krusei form mycelia along agar surfaces towards each other and other Candida species","volume":"17","author":"Fleischmann","year":"2017","journal-title":"BMC Microbiol"},{"key":"2021010319002736900_bib66","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1534\/genetics.116.194811","article-title":"Role of ectopic gene conversion in the evolution of a Candida krusei pleiotropic drug resistance transporter family","volume":"205","author":"Lamping","year":"2017","journal-title":"Genetics"},{"key":"2021010319002736900_bib67","doi-asserted-by":"crossref","first-page":"2883","DOI":"10.1534\/g3.117.043547","article-title":"Whole genome sequence of the heterozygous clinical isolate Candida krusei 81-B-5","volume":"7","author":"Cuomo","year":"2017","journal-title":"G3"},{"key":"2021010319002736900_bib68","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1080\/mmy.39.1.109.116","article-title":"Identification and expression of multidrug resistance related ABC transporter genes in Candida krusei","volume":"39","author":"Katiyar","year":"2001","journal-title":"Med Mycol"},{"key":"2021010319002736900_bib69","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1128\/EC.00229-12","article-title":"Genome sequence of Pichia kudriavzevii M12, a potential producer of bioethanol and phytase","volume":"11","author":"Chan","year":"2012","journal-title":"Eukaryot Cell"},{"key":"2021010319002736900_bib70","doi-asserted-by":"crossref","first-page":"e00064","DOI":"10.1128\/genomeA.00064-17","article-title":"Genome sequences of Cyberlindnera fabianii 65, Pichia kudriavzevii 129, and Saccharomyces cerevisiae 131 isolated from fermented masau fruits in Zimbabwe","volume":"5","author":"van Rijswijck","year":"2017","journal-title":"Genome Announc"},{"key":"2021010319002736900_bib71","doi-asserted-by":"crossref","first-page":"e01515","DOI":"10.1128\/genomeA.01515-17","article-title":"Draft genome sequence of a multistress-tolerant yeast, Pichia kudriavzevii NG7","volume":"6","author":"Park","year":"2018","journal-title":"Genome Announc"},{"key":"2021010319002736900_bib72","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1186\/s13568-018-0609-0","article-title":"Genomic and probiotic characterization of SJP-SNU strain of Pichia kudriavzevii","volume":"8","author":"Hong","year":"2018","journal-title":"AMB Express"},{"key":"2021010319002736900_bib73","first-page":"5966","article-title":"The 2019 updated list of QPS status recommended biological agents in support of EFSA risk assessments","volume":"18","author":"EFSA BIOHAZ Panel","year":"2020","journal-title":"EFSA J."},{"key":"2021010319002736900_bib74","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1051\/lait:1998657","article-title":"Study of the yeasts during the ripening process of Armada cheeses from raw goat's milk","volume":"78","author":"Tornadijo","year":"1998","journal-title":"Le Lait"},{"key":"2021010319002736900_bib75","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/j.idairyj.2004.08.022","article-title":"Cultures for the ripening of smear cheeses","volume":"15","author":"Bockelmann","year":"2005","journal-title":"Int Dairy J"},{"key":"2021010319002736900_bib76","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.lwt.2004.05.008","article-title":"Enumeration and identification of microflora in suusac, a Kenyan traditional fermented camel milk product","volume":"38","author":"Lore","year":"2005","journal-title":"LWT-Food Sci Technol"},{"key":"2021010319002736900_bib77","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.femsyr.2004.11.002","article-title":"Occurrence and diversity of yeasts involved in fermentation of West African cocoa beans","volume":"5","author":"Jespersen","year":"2005","journal-title":"FEMS Yeast Res"},{"key":"2021010319002736900_bib78","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.ijfoodmicro.2006.10.041","article-title":"Study on the microflora and biochemistry of cocoa fermentation in the Dominican Republic","volume":"114","author":"G\u00e1lvez","year":"2007","journal-title":"Int J Food Microbiol"},{"key":"2021010319002736900_bib79","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/S0168-1605(01)00431-7","article-title":"Characteristics and significance of yeasts\u2019 involvement in cassava fermentation for \u2018fufu\u2019 production","volume":"65","author":"Oyewole","year":"2001","journal-title":"Int J Food Microbiol"},{"key":"2021010319002736900_bib80","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/j.foodcont.2007.05.010","article-title":"Evaluation of diversity of Candida species isolated from fermented cassava during traditional small scale gari production in Nigeria","volume":"19","author":"Oguntoyinbo","year":"2008","journal-title":"Food Control"},{"key":"2021010319002736900_bib81","first-page":"1766","article-title":"Evaluation of hazards and critical control points of ogi in small scale processing centres in Abeokuta, Nigeria","volume":"29","author":"Omemu","year":"2010","journal-title":"J Appl Biosci"},{"key":"2021010319002736900_bib82","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/S0956-7135(97)00051-0","article-title":"Effect of cassava variety and processing methods on the performance of \u2018kudeme\u2019 in agbelima production","volume":"8","author":"Ellis","year":"1997","journal-title":"Food Control"},{"key":"2021010319002736900_bib83","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1023\/A:1008980912708","article-title":"Microbial characterization of yam fermentation for \u2018elubo\u2019 (yam flour) production","volume":"16","author":"Achi","year":"2000","journal-title":"World J Microbiol Biotechnol"},{"key":"2021010319002736900_bib84","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1023\/A:1020319103262","article-title":"Improvement of glycerol production by Candida krusei in batch and continuous cultures using corn steep liquor","volume":"24","author":"Liu","year":"2002","journal-title":"Biotechnol Lett"},{"key":"2021010319002736900_bib85","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/S1004-9541(06)60085-2","article-title":"Influence of osmoregulators on osmotolerant yeast Candida krusei for the production of glycerol","volume":"14","author":"Chen","year":"2006","journal-title":"Chin J Chem Eng"},{"key":"2021010319002736900_bib86","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1007\/s10295-010-0783-9","article-title":"Enrichment of a continuous culture of Saccharomyces cerevisiae with the yeast Issatchenkia orientalis in the production of ethanol at increasing temperatures","volume":"38","author":"Gallardo","year":"2011","journal-title":"J Ind Microbiol Biotechnol"},{"key":"2021010319002736900_bib87","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1002\/jctb.2151","article-title":"Processing of ethanol fermentation broth by Candida krusei to separate bioethanol by pervaporation using silicone rubber-coated silicate membranes","volume":"84","author":"Ikegami","year":"2009","journal-title":"J Chem Technol Biotechnol"},{"key":"2021010319002736900_bib88","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.ibiod.2005.05.006","article-title":"Screening and identification of yeasts for decolorizing synthetic dyes in industrial wastewater","volume":"56","author":"Yu","year":"2005","journal-title":"Int Biodeterior Biodegradation"},{"key":"2021010319002736900_bib89","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1007\/s10532-011-9472-2","article-title":"Biodegradation of basic violet 3 by Candida krusei isolated from textile wastewater","volume":"22","author":"Deivasigamani","year":"2011","journal-title":"Biodegradation"},{"key":"2021010319002736900_bib90","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1007\/BF02814437","article-title":"The histopathological characterization of oral Candida leukoplakias","volume":"46","author":"Dorko","year":"2001","journal-title":"Folia Microbiol"},{"key":"2021010319002736900_bib91","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1007\/s12281-008-0026-y","article-title":"Phenotypic switching in fungi","volume":"2","author":"Jain","year":"2008","journal-title":"Curr Fungal Infect Rep"},{"key":"2021010319002736900_bib92","first-page":"198","article-title":"Candida albicans switch phenotypes display differential levels of fitness","volume":"10","author":"Vargas","year":"2004","journal-title":"Med Sci Monit"},{"key":"2021010319002736900_bib93","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1111\/j.1567-1364.2011.00786.x","article-title":"Effect of phenotypic switching on the biological properties and susceptibility to chlorhexidine in Candida krusei ATCC 14243","volume":"12","author":"Arzmi","year":"2012","journal-title":"FEMS Yeast Res"},{"key":"2021010319002736900_bib94","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1128\/IAI.63.5.1993-1998.1995","article-title":"Evidence implicating phospholipase as a virulence factor of Candida albicans","volume":"63","author":"Ibrahim","year":"1995","journal-title":"Infect Immun"},{"key":"2021010319002736900_bib95","first-page":"65","article-title":"Possible role of secreted proteinases in Candida albicans infections","volume":"15","author":"Hube","year":"1998","journal-title":"Rev Iberoam Micol"},{"key":"2021010319002736900_bib96","first-page":"223","article-title":"Virulence factors of Candida species","volume":"36","author":"Yang","year":"2003","journal-title":"J Microbiol Immunol Infect"},{"key":"2021010319002736900_bib97","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.transproceed.2005.11.096","article-title":"Enzymatic variability of Candida krusei isolates in a course of fungal infection in a liver transplant recipient","volume":"38","author":"Kawecki","year":"2006","journal-title":"Transplant Proc"},{"key":"2021010319002736900_bib98","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1590\/S0036-46652010000300005","article-title":"Fernandes OdeFL, Silva MdoR. Differences in exoenzyme production and adherence ability of Candida spp. isolates from catheter, blood and oral cavity","volume":"52","author":"Costa","year":"2010","journal-title":"Rev Inst Med Trop S Paulo"},{"key":"2021010319002736900_bib99","doi-asserted-by":"crossref","first-page":"\u2013","DOI":"10.1086\/342300","article-title":"Secular trend of hospital-acquired candidemia among intensive care unit patients in the United States during 1989","volume":"35","author":"Trick","year":"2002","journal-title":"Clin Infect Dis"},{"key":"2021010319002736900_bib100","doi-asserted-by":"crossref","first-page":"\u2013","DOI":"10.1186\/1471-2334-10-312","article-title":"Secular trend in candidemia and the use of fluconazole in Finland, 2004","volume":"10","author":"Poikonen","year":"2010","journal-title":"BMC Infect Dis"},{"key":"2021010319002736900_bib101","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.jmii.2010.08.010","article-title":"Candida albicans versus non-albicans bloodstream infections: the comparison of risk factors and outcome","volume":"44","author":"Chi","year":"2011","journal-title":"J Microbiol Immunol Infect"},{"key":"2021010319002736900_bib102","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/s10123-018-0014-1","article-title":"The continuous changes in the aetiology and epidemiology of invasive candidiasis: from familiar Candida albicans to multiresistant Candida auris","volume":"21","author":"Quind\u00f3s","year":"2018","journal-title":"Int Microbiol"},{"key":"2021010319002736900_bib103","doi-asserted-by":"crossref","first-page":"S79","DOI":"10.1093\/ofid\/ofy358","article-title":"Twenty years of the SENTRY antifungal surveillance program: results for Candida species from 1997\u20132016","volume":"6","author":"Pfaller","year":"2019","journal-title":"Open Forum Infect Dis"},{"key":"2021010319002736900_bib104","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.idc.2015.10.013","article-title":"Invasive candidiasis","volume":"30","author":"McCarty","year":"2016","journal-title":"Infect Dis Clin North Am"},{"key":"2021010319002736900_bib105","doi-asserted-by":"crossref","first-page":"18026","DOI":"10.1038\/nrdp.2018.26","article-title":"Invasive candidiasis","volume":"4","author":"Pappas","year":"2018","journal-title":"Nat Rev Dis Primers"},{"key":"2021010319002736900_bib106","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.diagmicrobio.2012.10.003","article-title":"Epidemiology and outcomes of candidemia in 3648 patients: data from the Prospective Antifungal Therapy (PATH Alliance\u00ae) registry, 2004\u20132008","volume":"74","author":"Pfaller","year":"2012","journal-title":"Diagn Microbiol Infect Dis"},{"key":"2021010319002736900_bib107","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.diagmicrobio.2016.02.009","article-title":"Antifungal susceptibility patterns of a global collection of fungal isolates: results of the SENTRY antifungal surveillance program (2013)","volume":"85","author":"Castanheira","year":"2016","journal-title":"Diagn Microbiol Infect Dis"},{"key":"2021010319002736900_bib108","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1128\/JCM.02117-09","article-title":"Results from the ARTEMIS DISK global antifungal surveillance study. 1997 to 2007: a 10.5-year analysis of susceptibilities of Candida species to fluconazole and voriconazole as determined by CLSI standardized disk diffusion","volume":"48","author":"Pfaller","year":"2010","journal-title":"J Clin Microbiol"},{"key":"2021010319002736900_bib109","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.3201\/eid2407.171087","article-title":"Large outbreaks of fungal and bacterial bloodstream infections in a neonatal unit, South Africa, 2012\u20132016","volume":"24","author":"Van Schalkwyk","year":"2018","journal-title":"Emerg Infect Dis"},{"key":"2021010319002736900_bib110","doi-asserted-by":"crossref","first-page":"2493","DOI":"10.1002\/cncr.23466","article-title":"The changing epidemiology of invasive candidiasis","volume":"112","author":"Hachem","year":"2008","journal-title":"Cancer."},{"key":"2021010319002736900_bib111","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1056\/NEJM199110313251803","article-title":"Increase in Candida krusei infection among patients with bone marrow transplantation and neutropenia treated prophylactically with fluconazole","volume":"325","author":"Wingard","year":"1991","journal-title":"N Engl J Med"},{"key":"2021010319002736900_bib112","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1093\/jac\/dkh532","article-title":"Candida krusei fungaemia: antifungal susceptibility and clinical presentation of an uncommon entity during 15 years in a single general hospital","volume":"55","author":"Mu\u00f1oz","year":"2005","journal-title":"J Antimicrob Chemother"},{"key":"2021010319002736900_bib113","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1053\/jhin.2001.1151","article-title":"Non-albicans Candida spp. causing fungaemia: pathogenicity and antifungal resistance","volume":"50","author":"Krcmery","year":"2002","journal-title":"J Hosp Infect"},{"key":"2021010319002736900_bib114","first-page":"1131","article-title":"Epidemiology of non-albicans Candida spp","volume":"7","author":"Abi Said","year":"1998","journal-title":"Clin Infect Dis"},{"key":"2021010319002736900_bib115","doi-asserted-by":"crossref","first-page":"845\u2013-851","DOI":"10.1056\/NEJM199203263261301","article-title":"A controlled trial of fluconazole to prevent fungal infections in patients undergoing bone marrow transplantation","volume":"326","author":"Goodman","year":"1992","journal-title":"N Engl J Med"},{"key":"2021010319002736900_bib116","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1128\/JCM.34.7.1856-1858.1996","article-title":"Strain variation among and antifungal susceptibilities of isolates of Candida krusei","volume":"34","author":"Berrouane","year":"1996","journal-title":"J Clin Microbiol."},{"key":"2021010319002736900_bib117","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1007\/s10096-006-0200-5","article-title":"Slow response of invasive Candida krusei infection to amphotericin B in a clinical time-kill study","volume":"25","author":"Majoros","year":"2006","journal-title":"Europ J Clin Microbiol Infect Dis"},{"key":"2021010319002736900_bib118","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1080\/13693780600686929","article-title":"Successful treatment of Candida krusei fungemia with amphotericin B and caspofungin","volume":"44","author":"Olver","year":"2006","journal-title":"Med Mycol"},{"key":"2021010319002736900_bib119","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1128\/JCM.01915-07","article-title":"Candida krusei, a multidrug-resistant opportunistic fungal pathogen: geographic and temporal trends from the ARTEMIS DISK antifungal surveillance program, 2001 to 2005","volume":"46","author":"Pfaller","year":"2008","journal-title":"J Clin Microbiol"},{"key":"2021010319002736900_bib120","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/S0924-8579(00)00191-6","article-title":"Activity of voriconazole against Candida albicans and Candida krusei isolated since 1984","volume":"16","author":"Lee","year":"2000","journal-title":"Int J Antimicrob Agents"},{"key":"2021010319002736900_bib121","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1128\/AAC.47.4.1213-1219.2003","article-title":"Genetic basis for differential activities of fluconazole and voriconazole against Candida krusei","volume":"47","author":"Fukuoka","year":"2003","journal-title":"Antimicrob Agents Chemother"},{"key":"2021010319002736900_bib122","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1002\/phar.1652","article-title":"Isavuconazole: pharmacology, pharmacodynamics, and current clinical experience with a new triazole antifungal agent","volume":"35","author":"Rybak","year":"2015","journal-title":"Pharmacotherapy"},{"key":"2021010319002736900_bib123","doi-asserted-by":"crossref","first-page":"2006","DOI":"10.1128\/AAC.02615-13","article-title":"Multilaboratory study of epidemiological cutoff values for detection of resistance in eight Candida species to fluconazole, posaconazole, and voriconazole","volume":"58","author":"Espinel-Ingroff","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"key":"2021010319002736900_bib124","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.diagmicrobio.2015.04.008","article-title":"Isavuconazole, micafungin, and 8 comparator antifungal agents\u2019 susceptibility profiles for common and uncommon opportunistic fungi collected in 2013: temporal analysis of antifungal drug resistance using CLSI species-specific clinical breakpoints and proposed epidemiological cutoff values","volume":"82","author":"Pfaller","year":"2015","journal-title":"Diagn Microbiol Infect Dis"},{"key":"2021010319002736900_bib125","doi-asserted-by":"crossref","first-page":"3300","DOI":"10.1128\/JCM.00179-11","article-title":"Diagnostic issues, clinical characteristics, and outcomes for patients with fungemia","volume":"49","author":"Arendrup","year":"2011","journal-title":"J Clin Microbiol"},{"key":"2021010319002736900_bib126","doi-asserted-by":"crossref","first-page":"2522","DOI":"10.1128\/AAC.00148-06","article-title":"Emergence of a Candida krusei isolate with reduced susceptibility to caspofungin during therapy","volume":"50","author":"Hakki","year":"2006","journal-title":"Antimicrob Agents Chemother"},{"key":"2021010319002736900_bib127","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1128\/JCM.02120-10","article-title":"Use of epidemiological cutoff values to examine 9-year trends in susceptibility of Candida species to anidulafungin, caspofungin, and micafungin","volume":"49","author":"Pfaller","year":"2011","journal-title":"J Clin Microbiol"},{"key":"2021010319002736900_bib128","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.jfda.2016.12.014","article-title":"Evaluation of synergistic anticandidal and apoptotic effects of ferulic acid and caspofungin against Candida albicans","volume":"26","author":"Canturk","year":"2018","journal-title":"J Food Drug Anal"},{"key":"2021010319002736900_bib129","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1093\/clinids\/24.2.235","article-title":"Development of interpretive breakpoints for antifungal susceptibility testing: conceptual framework and analysis of in vitro-in vivo correlation data for fluconazole, itraconazole, and Candida infections","volume":"24","author":"Rex","year":"1997","journal-title":"Clin Infect Dis"},{"key":"2021010319002736900_bib130","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1038\/nrmicro1179","article-title":"Evolution of antifungal-drug resistance: mechanisms and pathogen fitness","volume":"3","author":"Anderson","year":"2005","journal-title":"Nature Rev Microbiol"},{"key":"2021010319002736900_bib131","doi-asserted-by":"crossref","first-page":"2701","DOI":"10.1099\/00221287-145-10-2701","article-title":"Contribution of mutations in the cytochrome P450 14\u03b1-demethylase (Erg11p, Cyp51p) to azole resistance in Candida albicans","volume":"145","author":"Marichal","year":"1999","journal-title":"Microbiology"},{"key":"2021010319002736900_bib132","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1093\/jac\/dks481","article-title":"Mechanisms of azole resistance in 52 clinical isolates of Candida tropicalis in China","volume":"68","author":"Jiang","year":"2013","journal-title":"J Antimicrob Chemother"},{"key":"2021010319002736900_bib133","first-page":"386","volume":"13","author":"Xiang","year":"2013","journal-title":"Erg11 mutations associated with azole resistance in clinical isolates of Candida albicans. FEMS Yeast Res."},{"key":"2021010319002736900_bib134","doi-asserted-by":"crossref","first-page":"e02496","DOI":"10.1128\/AAC.02496-16","article-title":"ERG11 gene mutations and MDR1 upregulation confer pan-azole resistance in Candida tropicalis causing disseminated candidiasis in an acute lymphoblastic leukemia patient on posaconazole prophylaxis","volume":"61","author":"You","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"key":"2021010319002736900_bib135","doi-asserted-by":"crossref","first-page":"2645","DOI":"10.1128\/AAC.42.10.2645","article-title":"Mechanism of fluconazole resistance in Candida krusei","volume":"42","author":"Orozco","year":"1998","journal-title":"Antimicrob Agents Chemother"},{"key":"2021010319002736900_bib136","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1080\/02681219780000821","article-title":"Inhibition and interaction of cytochrome P450 of Candida krusei with azole antifungal drugs","volume":"35","author":"Venkateswarlu","year":"1997","journal-title":"Med Mycol"},{"key":"2021010319002736900_bib137","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1128\/AAC.01095-08","article-title":"Abc1p is a multidrug efflux transporter that tips the balance in favor of innate azole resistance in Candida krusei","volume":"53","author":"Lamping","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"2021010319002736900_bib138","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1128\/AAC.49.5.1745-1752.2005","article-title":"Candida albicans zinc cluster protein Upc2p confers resistance to antifungal drugs and is an activator of ergosterol biosynthetic genes","volume":"49","author":"MacPherson","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"key":"2021010319002736900_bib139","first-page":"276","article-title":"Upregulation of the ERG11 gene in Candida krusei by azoles","volume":"18","author":"Tavakoli","year":"2010","journal-title":"Daru"},{"key":"2021010319002736900_bib140","doi-asserted-by":"crossref","first-page":"e0136185","DOI":"10.1371\/journal.pone.0136185","article-title":"Overexpression of both ERG11 and ABC2 genes might be responsible for itraconazole resistance in clinical isolates of Candida krusei","volume":"10","author":"He","year":"2015","journal-title":"PLoS One"},{"key":"2021010319002736900_bib141","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1128\/MMBR.62.1.1-34.1998","article-title":"Major facilitator superfamily","volume":"62","author":"Pao","year":"1998","journal-title":"Microbiol Mol Biol Rev"},{"key":"2021010319002736900_bib142","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1038\/nrm2646","article-title":"ABC transporters: the power to change","volume":"10","author":"Rees","year":"2009","journal-title":"Nat Rev Mol Cell Biol"},{"key":"2021010319002736900_bib143","doi-asserted-by":"crossref","first-page":"e954","DOI":"10.1016\/j.ijid.2010.04.006","article-title":"Relative frequency of albicans and the various non-albicans Candida spp. among candidemia isolates from inpatients in various parts of the world: a systematic review","volume":"14","author":"Falagas","year":"2010","journal-title":"Int J Infect Dis"},{"key":"2021010319002736900_bib144","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.ijantimicag.2006.03.012","article-title":"Antifungal drug resistance: limited data, dramatic impact","volume":"27","author":"Rogers","year":"2006","journal-title":"Int J Antimicrob Agents."},{"key":"2021010319002736900_bib145","doi-asserted-by":"crossref","first-page":"4604","DOI":"10.1128\/AAC.02603-14","article-title":"In vivo and in vitro acquisition of resistance to voriconazole by Candida krusei","volume":"58","author":"Ricardo","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"key":"2021010319002736900_bib146","doi-asserted-by":"crossref","first-page":"e1001692","DOI":"10.1371\/journal.pbio.1001692","article-title":"Fitness trade-offs restrict the evolution of resistance to amphotericin B","volume":"11","author":"Vincent","year":"2013","journal-title":"PLoS Biol"},{"key":"2021010319002736900_bib147","doi-asserted-by":"crossref","first-page":"2717","DOI":"10.1128\/AAC.47.9.2717-2724.2003","article-title":"Disruption of ergosterol biosynthesis confers resistance to amphotericin B in Candida lusitaniae","volume":"47","author":"Young","year":"2003","journal-title":"Antimicrob Agents Chemother"},{"key":"2021010319002736900_bib148","first-page":"254","article-title":"Antifungal drug resistance in Candida species","volume":"10","author":"Sheikh","year":"2013","journal-title":"Eur J Gen Med"},{"key":"2021010319002736900_bib149","doi-asserted-by":"crossref","first-page":"11","DOI":"10.3389\/fmed.2016.00011","article-title":"Emerging threats in antifungal-resistant fungal pathogens","volume":"3","author":"Sanglard","year":"2016","journal-title":"Front Med"},{"key":"2021010319002736900_bib150","doi-asserted-by":"crossref","first-page":"3701","DOI":"10.1128\/AAC.00423-08","article-title":"A nonsense mutation in the ERG6 gene leads to reduced susceptibility to polyenes in a clinical isolate of Candida glabrata","volume":"52","author":"Vandeputte","year":"2008","journal-title":"Antimicrob Agents Chemother"},{"key":"2021010319002736900_bib151","doi-asserted-by":"crossref","first-page":"3578","DOI":"10.1128\/AAC.00303-10","article-title":"A clinical isolate of Candida albicans with mutations in ERG11 (encoding Sterol 14\u03b1-demethylase) and ERG5 (encoding C22 desaturase) is cross resistant to azoles and amphotericin B","volume":"54","author":"Martel","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"key":"2021010319002736900_bib152","doi-asserted-by":"crossref","first-page":"6417","DOI":"10.1128\/AAC.01145-12","article-title":"Two clinical isolates of Candida glabrata exhibiting reduced sensitivity to amphotericin B both harbor mutations in ERG2","volume":"56","author":"Hull","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"key":"2021010319002736900_bib153","doi-asserted-by":"crossref","first-page":"2551","DOI":"10.1093\/jac\/dkv140","article-title":"Stepwise emergence of azole, echinocandin and amphotericin B multidrug resistance in vivo in Candida albicans orchestrated by multiple genetic alterations","volume":"70","author":"Jensen","year":"2015","journal-title":"J Antimicrob Chemother"},{"key":"2021010319002736900_bib154","doi-asserted-by":"crossref","first-page":"5729","DOI":"10.1128\/JCM.41.12.5729-5731.2003","article-title":"Caspofungin activity against clinical isolates of fluconazole-resistant Candida","volume":"41","author":"Pfaller","year":"2003","journal-title":"J Clin Microbiol"},{"key":"2021010319002736900_bib155","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1097\/QCO.0000000000000111","article-title":"Echinocandin resistance","volume":"27","author":"Arendrup","year":"2014","journal-title":"Curr Opin Infect Dis"},{"key":"2021010319002736900_bib156","doi-asserted-by":"crossref","first-page":"Art 713687","DOI":"10.1155\/2012\/713687","article-title":"Antifungal resistance and new strategies to control fungal infections","volume":"2012","author":"Vandeputte","year":"2012","journal-title":"Int J Microbiol"},{"key":"2021010319002736900_bib157","doi-asserted-by":"crossref","first-page":"3264","DOI":"10.1128\/AAC.49.8.3264-3273.2005","article-title":"Specific substitutions in the echinocandin target Fks1p account for reduced susceptibility of rare laboratory and clinical Candida sp. isolates","volume":"49","author":"Park","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"key":"2021010319002736900_bib158","doi-asserted-by":"crossref","first-page":"461","DOI":"10.3390\/genes9090461","article-title":"Evolutionary emergence of drug resistance in Candida opportunistic pathogens","volume":"9","author":"Ksiezopolska","year":"2018","journal-title":"Genes"},{"key":"2021010319002736900_bib159","doi-asserted-by":"crossref","first-page":"2305","DOI":"10.1128\/AAC.00262-08","article-title":"A naturally occurring proline-to-alanine amino acid change in Fks1p in Candida parapsilosis, Candida orthopsilosis, and Candida metapsilosis accounts for reduced echinocandin susceptibility","volume":"52","author":"Garcia-Effron","year":"2008","journal-title":"Antimicrob Agents Chemother"},{"key":"2021010319002736900_bib160","first-page":"1","article-title":"Resistance in human pathogenic yeasts and filamentous fungi: prevalence, underlying molecular mechanisms and link to the use of antifungals in humans and the environment","volume":"63","author":"Jensen","year":"2016","journal-title":"Dan Med J"},{"key":"2021010319002736900_bib161","doi-asserted-by":"crossref","first-page":"3550","DOI":"10.1128\/AAC.02367-14","article-title":"Echinocandin failure case due to a previously unreported FKS1 mutation in Candida krusei","volume":"58","author":"Jensen","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"key":"2021010319002736900_bib162","doi-asserted-by":"crossref","first-page":"a019752","DOI":"10.1101\/cshperspect.a019752","article-title":"Mechanisms of antifungal drug resistance","volume":"5","author":"Cowen","year":"2015","journal-title":"Cold Spring Harb Perspect Med"},{"key":"2021010319002736900_bib163","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1093\/infdis\/jir351","article-title":"Fitness and virulence costs of Candida albicans FKS1 hot spot mutations associated with echinocandin resistance","volume":"204","author":"Ben-Ami","year":"2011","journal-title":"J Infect Dis"},{"key":"2021010319002736900_bib164","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1111\/j.1365-2958.2007.05588.x","article-title":"The PKC, HOG and Ca2+ signalling pathways co-ordinately regulate chitin synthesis in Candida albicans","volume":"63","author":"Munro","year":"2007","journal-title":"Mol Microbiol"},{"key":"2021010319002736900_bib165","doi-asserted-by":"crossref","first-page":"e1000040","DOI":"10.1371\/journal.ppat.1000040","article-title":"Stimulation of chitin synthesis rescues Candida albicans from echinocandins","volume":"4","author":"Walker","year":"2008","journal-title":"PLoS Pathog"},{"key":"2021010319002736900_bib166","doi-asserted-by":"crossref","first-page":"528521","DOI":"10.1155\/2012\/528521","article-title":"Fungal biofilm resistance","volume":"2012","author":"Ramage","year":"2012","journal-title":"Int J Microbiol"},{"key":"2021010319002736900_bib167","doi-asserted-by":"crossref","first-page":"a019729","DOI":"10.1101\/cshperspect.a019729","article-title":"Fungal biofilms, drug resistance, and recurrent infection","volume":"4","author":"Desai","year":"2014","journal-title":"Cold Spring Harb Perspect Med"},{"key":"2021010319002736900_bib168","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1038\/nrmicro2475","article-title":"Genetic control of Candida albicans biofilm development","volume":"9","author":"Finkel","year":"2011","journal-title":"Nat Rev Microbiol"},{"key":"2021010319002736900_bib169","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1111\/j.1567-1364.2006.00150.x","article-title":"Chromosome instability in Candida albicans","volume":"7","author":"Rustchenko","year":"2007","journal-title":"FEMS Yeast Res"},{"key":"2021010319002736900_bib170","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1128\/EC.00060-10","article-title":"Genomic plasticity of the human fungal pathogen Candida albicans","volume":"9","author":"Selmecki","year":"2010","journal-title":"Eukaryot Cell"},{"key":"2021010319002736900_bib171","doi-asserted-by":"crossref","first-page":"594","DOI":"10.3109\/1040841X.2014.974500","article-title":"Novel strategies to fight Candida species infection","volume":"42","author":"Rodrigues","year":"2016","journal-title":"Crit Rev Microbiol"},{"key":"2021010319002736900_bib172","doi-asserted-by":"crossref","first-page":"S328","DOI":"10.1093\/mmy\/myz012","article-title":"Antifungal drugs: what brings the future","volume":"57","author":"Van Deale","year":"2019","journal-title":"Med Mycol"},{"key":"2021010319002736900_bib173","doi-asserted-by":"crossref","first-page":"6872","DOI":"10.1128\/AAC.00701-16","article-title":"Preclinical evaluation of the stability, safety, and efficacy of CD101, a novel echinocandin","volume":"60","author":"Ong","year":"2016","journal-title":"Antimicrob Agents Chemother"},{"key":"2021010319002736900_bib174","doi-asserted-by":"crossref","first-page":"e01627","DOI":"10.1128\/AAC.01627-16","article-title":"Safety and pharmacokinetics of CD101 IV, a novel echinocandin, in healthy adults","volume":"61","author":"Sandison","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"key":"2021010319002736900_bib175","doi-asserted-by":"crossref","first-page":"e01009","DOI":"10.1128\/AAC.01009-17","article-title":"Unraveling drug penetration of echinocandin antifungals at the site of infection in an intra-abdominal abscess model","volume":"61","author":"Zhao","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"key":"2021010319002736900_bib176","doi-asserted-by":"crossref","first-page":"3505","DOI":"10.1093\/jac\/dkz390","article-title":"In vitro activity of rezafungin against common andrare Candida species and Saccharomyces cerevisiae","volume":"74","author":"T\u00f3th","year":"2019","journal-title":"J Antimicrob Chemother"},{"key":"2021010319002736900_bib177","doi-asserted-by":"crossref","first-page":"e02068","DOI":"10.1128\/AAC.02068-16","article-title":"Preclinical pharmacokinetics and pharmacodynamics target of SCY-078, a first-in-class orally active antifungal glucan synthesis inhibitor, in murine models of disseminated candidiasis","volume":"61","author":"Wring","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"key":"2021010319002736900_bib178","doi-asserted-by":"crossref","first-page":"e01961","DOI":"10.1128\/AAC.01961-16","article-title":"SCY-078 is fungicidal against Candida species in time-kill studies","volume":"61","author":"Scorneaux","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"key":"2021010319002736900_bib179","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1080\/21505594.2016.1196301","article-title":"Repurposing auranofin as an antifungal: in vitro activity against a variety of medically important fungi","volume":"8","author":"Wiederhold","year":"2017","journal-title":"Virulence"},{"key":"2021010319002736900_bib180","first-page":"e01084","article-title":"Screening a repurposing library for inhibitors of multidrug-resistant Candida auris identifies ebselen as a repositionable candidate for antifungal drug development","volume":"61","author":"Wall","year":"2018","journal-title":"Antimicrob Agents Chemother"},{"key":"2021010319002736900_bib181","doi-asserted-by":"crossref","first-page":"336","DOI":"10.3389\/fmicb.2018.00336","article-title":"Repurposing auranofin, ebselen, and PX-12 as antimicrobial agents targeting the thioredoxin system","volume":"9","author":"May","year":"2018","journal-title":"Front Microbiol"},{"key":"2021010319002736900_bib182","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.fob.2014.01.002","article-title":"Ebselen induces reactive oxygen species (ROS)-mediated cytotoxicity in Saccharomyces cerevisiae with inhibition of glutamate dehydrogenase being a target","volume":"4","author":"Azad","year":"2014","journal-title":"FEBS Open Bio"},{"key":"2021010319002736900_bib183","doi-asserted-by":"crossref","first-page":"3002","DOI":"10.1016\/j.bbagen.2016.09.029","article-title":"Ebselen exerts antifungal activity by regulating glutathione (GSH) and reactive oxygen species (ROS) production in fungal cells","volume":"1861","author":"Thangamani","year":"2017","journal-title":"Biochim Biophys Acta Gen Subj"},{"key":"2021010319002736900_bib184","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1111\/j.1439-0507.2009.01747.x","article-title":"In vitro synergistic effects of metergoline and antifungal agents against Candida krusei","volume":"53","author":"Kang","year":"2009","journal-title":"Mycoses"},{"key":"2021010319002736900_bib185","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1080\/21505594.2016.1257457","article-title":"New facets of antifungal therapy","volume":"8","author":"Chang","year":"2017","journal-title":"Virulence"},{"key":"2021010319002736900_bib186","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1042\/EBC20160067","article-title":"Resistance to antifungal therapies","volume":"61","author":"Prasad","year":"2017","journal-title":"Essays Biochem"},{"key":"2021010319002736900_bib187","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1080\/13693780701552996","article-title":"Successfully treated Candida krusei infection of the lumbar spine with combined caspofungin\/posaconazole therapy","volume":"46","author":"Schilling","year":"2008","journal-title":"Med Mycol"},{"key":"2021010319002736900_bib188","first-page":"859","article-title":"In vitro combination therapy with isavuconazole against Candida spp","volume":"55","author":"Katragkou","year":"2017","journal-title":"Med Mycol"},{"key":"2021010319002736900_bib189","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1093\/emboj\/21.4.546","article-title":"Calcineurin is essential for survival during membrane stress in Candida albicans","volume":"21","author":"Cruz","year":"2002","journal-title":"EMBO J"},{"key":"2021010319002736900_bib190","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1128\/AAC.47.3.956-964.2003","article-title":"Ergosterol biosynthesis inhibitors become fungicidal when combined with calcineurin Inhibitors against Candida albicans, Candida glabrata, and Candida krusei","volume":"47","author":"Onyewu","year":"2003","journal-title":"Antimicrob Agents Chemother"},{"key":"2021010319002736900_bib191","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1093\/mmy\/myu046","article-title":"Synergistic effect of amphotericin B and tyrosol on biofilm formed by Candida krusei and Candida tropicalis from intrauterine device users","volume":"52","author":"Shanmughapriya","year":"2014","journal-title":"Med Mycol"},{"key":"2021010319002736900_bib192","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.micpath.2017.04.021","article-title":"Synergistic anticandidal activity of menthol in combination with itraconazole and nystatin against clinical Candida glabrata and Candida krusei isolates","volume":"107","author":"Sharifzadeh","year":"2017","journal-title":"Microb Pathog"},{"key":"2021010319002736900_bib193","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1080\/13880209.2016.1242631","article-title":"In vitro synergism of a water insoluble fraction of Uncaria tomentosa combined with fluconazole and terbinafine against resistant non-Candida albicans isolates","volume":"55","author":"Moraes","year":"2017","journal-title":"Pharm Biol"},{"key":"2021010319002736900_bib194","first-page":"25","article-title":"Comparative study of disk diffusion and microdilution methods for evaluation of antifungal activity of natural compounds against medical yeasts Candida spp. and Cryptococcus sp","volume":"28","author":"Scorzoni","year":"2007","journal-title":"J Appl Pharm Sci"},{"key":"2021010319002736900_bib195","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1186\/1472-6882-11-119","article-title":"In vitro activities of natural products against oral Candida isolates from denture wearers","volume":"11","author":"Marcos-Arias","year":"2011","journal-title":"BMC Complement Altern Med"},{"key":"2021010319002736900_bib196","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1111\/j.1472-765X.2011.03032.x","article-title":"Enhanced activity of antifungal drugs using natural phenolics against yeast strains of Candida and Cryptococcus","volume":"52","author":"Faria","year":"2011","journal-title":"Lett Appl Microbiol"},{"key":"2021010319002736900_bib197","doi-asserted-by":"crossref","first-page":"904","DOI":"10.3109\/13693781003739351","article-title":"Novel antifungal activity of purpurin against Candida species in vitro","volume":"48","author":"Kang","year":"2010","journal-title":"Med Mycol"},{"key":"2021010319002736900_bib198","doi-asserted-by":"crossref","first-page":"2000","DOI":"10.1128\/AAC.48.6.2000-2006.2004","article-title":"Susceptibility of Candida species to photodynamic effects of photofrin","volume":"48","author":"Bliss","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"key":"2021010319002736900_bib199","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1590\/S1517-83822010000100009","article-title":"Photodynamic inactivation of four Candida species induced by Photogem\u00ae","volume":"41","author":"Dovigo","year":"2010","journal-title":"Braz J Microbiol"},{"key":"2021010319002736900_bib200","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.jphotobiol.2005.12.002","article-title":"Photosensitization of different Candida species by low power laser light","volume":"83","author":"De Souza","year":"2006","journal-title":"J Photochem Photobiol B"},{"key":"2021010319002736900_bib201","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1111\/j.1751-1097.2011.01053.x","article-title":"In vitro fungicidal photodynamic effect of hypericin on Candida species","volume":"88","author":"Rezusta","year":"2012","journal-title":"Photochem Photobiol"},{"key":"2021010319002736900_bib202","doi-asserted-by":"crossref","first-page":"D667","DOI":"10.1093\/nar\/gkr945","article-title":"The Candida genome database incorporates multiple Candida species: multispecies search and analysis tools with curated gene and protein information for Candida albicans and Candida glabrata","volume":"40","author":"Inglis","year":"2011","journal-title":"Nucleic Acids Res"},{"key":"2021010319002736900_bib203","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1177\/0022034508329273","article-title":"Molecular and cellular mechanisms that lead to Candida bofilm formation","volume":"88","author":"ten Cate","year":"2009","journal-title":"J Dent Res"},{"key":"2021010319002736900_bib204","doi-asserted-by":"crossref","first-page":"2659","DOI":"10.1001\/archinte.160.17.2659","article-title":"Candida krusei fungemia: an escalating serious infection in immunocompromised patients","volume":"160","author":"Abbas","year":"2000","journal-title":"Arch Intern Med"},{"key":"2021010319002736900_bib205","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1097\/01.idc.0000221454.07790.75","article-title":"Severe soft tissue abscess caused by Candida krusei","volume":"14","author":"Jiang","year":"2006","journal-title":"Infect Dis Clin Pract"},{"key":"2021010319002736900_bib206","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1093\/clinids\/14.2.472","article-title":"Invasive infections due to Candida krusei: report of ten cases of fungemia that include three cases of endophthalmitis","volume":"14","author":"McQuillen","year":"1992","journal-title":"Clin Infect Dis"},{"key":"2021010319002736900_bib207","doi-asserted-by":"crossref","first-page":"1912","DOI":"10.1128\/JCM.44.5.1912-1914.2006","article-title":"Spondylodiscitis caused by Candida krusei: case report and susceptibility patterns","volume":"44","author":"Peman","year":"2006","journal-title":"J Clin Microbiol"},{"key":"2021010319002736900_bib208","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1046\/j.1469-0691.2002.00488.x","article-title":"Pneumonia due to Candida krusei","volume":"8","author":"Petrocheilou-Paschou","year":"2002","journal-title":"Clin Microbiol Infect"},{"key":"2021010319002736900_bib209","doi-asserted-by":"crossref","first-page":"4479","DOI":"10.1128\/JCM.40.12.4479-4485.2002","article-title":"High oral prevalence of Candida krusei in leprosy patients in northern Thailand","volume":"40","author":"Reichart","year":"2002","journal-title":"J Clin Microbiol"},{"key":"2021010319002736900_bib210","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1038\/sj.bmt.1703252","article-title":"Candida glabrata and Candida krusei fungemia after high-risk allogeneic marrow transplantation: no adverse effect of low-dose fluconazole prophylaxis on incidence and outcome","volume":"28","author":"Safdar","year":"2001","journal-title":"Bone Marrow Transplant"},{"key":"2021010319002736900_bib211","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1086\/343826","article-title":"Vaginitis due to Candida krusei: epidemiology, clinical aspects, and therapy","volume":"35","author":"Singh","year":"2002","journal-title":"Clin Infect Dis"},{"key":"2021010319002736900_bib212","first-page":"551","article-title":"Ureteral obstruction of a renal allograft secondary to Candida krusei","volume":"20","author":"Thomalla","year":"1998","journal-title":"Transplant Proc"}],"container-title":["Medical Mycology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/mmy\/article-pdf\/59\/1\/14\/35115672\/myaa031.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/mmy\/article-pdf\/59\/1\/14\/35115672\/myaa031.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,21]],"date-time":"2022-10-21T03:09:39Z","timestamp":1666321779000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/mmy\/article\/59\/1\/14\/5836561"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,13]]},"references-count":212,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,5,13]]},"published-print":{"date-parts":[[2021,1,4]]}},"URL":"https:\/\/doi.org\/10.1093\/mmy\/myaa031","relation":{},"ISSN":["1369-3786","1460-2709"],"issn-type":[{"value":"1369-3786","type":"print"},{"value":"1460-2709","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2021,1]]},"published":{"date-parts":[[2020,5,13]]}}}